Full Text (PDF)
Abstract
In the early of 2020, people are challenging a pandemic in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 causes coronavirus disease, abbreviated as COVID-19. At the time of this writing, SARS-CoV-2 is spreading in multiple countries worldwide. There are above two million cases in different region of world. This virus appears to be a new human pathogen. Currently there are no vaccines, monoclonal antibodies (mAbs), or drugs available for SARS-CoV-2, though many are in rapid development and some may be accessible in a short time. This aim of this review that human convalescent serum is an option for stoppage and treatment of COVID-19 disease. Explain main advantage of convalescent serum, in addition to disadvantage of this method.
Keywords
License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article Type: Review Article
EUROPEAN J MED ED TE, Volume 13, Issue 1, March 2020, Article No: em2005
https://doi.org/10.30935/ejmets/8016
Publication date: 22 Apr 2020
Article Views: 2266
Article Downloads: 1307
Open Access References How to cite this article